IN2014CN03920A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03920A
IN2014CN03920A IN3920CHN2014A IN2014CN03920A IN 2014CN03920 A IN2014CN03920 A IN 2014CN03920A IN 3920CHN2014 A IN3920CHN2014 A IN 3920CHN2014A IN 2014CN03920 A IN2014CN03920 A IN 2014CN03920A
Authority
IN
India
Prior art keywords
mice
mouse
encoding sequence
replacement
human
Prior art date
Application number
Inventor
Li Hsien Wang
Jr Anthony T Dore
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IN2014CN03920A publication Critical patent/IN2014CN03920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

Mice that comprise a replacement of endogenous mouse IL 6 and/or IL 6 receptor genes are described and methods for making and using the mice. Mice comprising a replacement at an endogenous IL 6Ra locus of mouse ectodomain encoding sequence with human ectodomain encoding sequence is provided. Mice comprising a human IL 6 gene under control of mouse IL 6 regulatory elements is also provided including mice that have a replacement of mouse IL 6 encoding sequence with human IL 6 encoding sequence at an endogenous mouse IL 6 locus.
IN3920CHN2014 2011-10-28 2012-10-29 IN2014CN03920A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (1)

Publication Number Publication Date
IN2014CN03920A true IN2014CN03920A (en) 2015-09-04

Family

ID=47295138

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3920CHN2014 IN2014CN03920A (en) 2011-10-28 2012-10-29

Country Status (28)

Country Link
US (9) US8878001B2 (en)
EP (2) EP2818478B1 (en)
JP (2) JP6120451B2 (en)
KR (2) KR102084927B1 (en)
CN (2) CN108866101A (en)
AU (1) AU2015207889B2 (en)
BR (1) BR112014008529A2 (en)
CA (1) CA2853731C (en)
CY (2) CY1116614T1 (en)
DK (2) DK2818478T3 (en)
ES (2) ES2525368T3 (en)
HK (2) HK1190408A1 (en)
HR (2) HRP20141192T1 (en)
HU (1) HUE033400T2 (en)
IL (4) IL231896B (en)
IN (1) IN2014CN03920A (en)
LT (1) LT2818478T (en)
MX (1) MX358390B (en)
MY (2) MY172726A (en)
PL (2) PL2663575T3 (en)
PT (2) PT2818478T (en)
RS (2) RS55949B1 (en)
RU (2) RU2751240C2 (en)
SG (3) SG10201600965YA (en)
SI (2) SI2818478T1 (en)
SM (1) SMT201400187B (en)
WO (1) WO2013063556A1 (en)
ZA (1) ZA201402635B (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4049535A1 (en) 2009-10-06 2022-08-31 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
KR20230145500A (en) 2011-02-15 2023-10-17 리제너론 파마슈티칼스 인코포레이티드 Humanized m-csf mice
PT2818478T (en) 2011-10-28 2017-05-12 Regeneron Pharma Humanized il-6 and il-6 receptor
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
EP4193834A1 (en) 2012-09-07 2023-06-14 Yale University Genetically modified non-human animals and methods of use thereof
SG11201501924UA (en) * 2012-09-13 2015-05-28 Chugai Pharmaceutical Co Ltd Gene knock-in non-human animal
NZ631614A (en) 2012-11-05 2016-10-28 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
LT2958937T (en) 2013-02-22 2018-11-26 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
FI3434101T3 (en) * 2013-09-23 2023-10-02 Regeneron Pharma Non-human animals having a humanized signal-regulatory protein gene
RS58465B1 (en) * 2013-10-15 2019-04-30 Regeneron Pharma Humanized il-15 animals
ES2700972T3 (en) 2013-11-19 2019-02-20 Regeneron Pharma Non-human animals that have a humanized B cell activating factor gene
CA2929774C (en) 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animal cells having a humanized proliferation-inducing ligand gene
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
AU2015315834B2 (en) 2014-01-31 2019-12-12 Boehringer Ingelheim International Gmbh Novel anti-BAFF antibodies
PL3129400T3 (en) 2014-04-08 2020-09-07 Regeneron Pharmaceuticals, Inc. Non-human animals having humanized fc-gamma receptors
CA3225091A1 (en) 2014-05-05 2015-11-12 Regeneron Pharmaceuticals, Inc. Humanized c5 and c3 animals
NO2785538T3 (en) * 2014-05-07 2018-08-04
KR102627332B1 (en) 2014-05-19 2024-01-26 리제너론 파마슈티칼스 인코포레이티드 Genetically modified non-human animals expressing human epo
US9497945B2 (en) 2014-05-30 2016-11-22 Regeneron Pharmaceuticals, Inc. Humanized dipeptidyl peptidase IV (DPP4) animals
KR102482295B1 (en) * 2014-06-19 2022-12-30 리제너론 파마슈티칼스 인코포레이티드 Non-human animals having a humanized programmed cell death 1 gene
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
KR20170120090A (en) 2014-11-24 2017-10-30 리제너론 파마슈티칼스 인코포레이티드 Non-human animals expressing humanized cd3 complex
BR112017010490A2 (en) * 2014-12-05 2018-04-03 Regeneron Pharma rodent, cd47 polypeptide, isolated rodent cell or tissue, rodent entrepreneurial stem cell, rodent embryo, and methods of producing a rodent, grafting human cells into a rodent, evaluating efficacy therapy of a drug directed to human cells and to evaluate the pharmacokinetic properties, to evaluate the specific and unspecific toxicity of a drug directed to human cd47.
CA2976319C (en) 2015-02-20 2023-06-27 Ultrahaptics Ip Limited Algorithm improvements in a haptic system
US9841819B2 (en) 2015-02-20 2017-12-12 Ultrahaptics Ip Ltd Perceptions in a haptic system
CN107666828B (en) 2015-04-06 2021-04-09 瑞泽恩制药公司 Humanized T cell-mediated immune response in non-human animals
RU2020124128A (en) 2015-04-13 2020-09-22 Ридженерон Фармасьютикалз, Инк. SIRPA-IL15 HUMANIZED MICE WITH NOKIN AND METHODS OF THEIR USE
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
SG11201803409UA (en) 2015-11-20 2018-05-30 Regeneron Pharma Non-human animals having a humanized lymphocyte-activation gene 3
DK3782639T3 (en) 2015-12-08 2022-08-29 Regeneron Pharma Compositions and methods for internalizing enzymes
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
AU2017213627B2 (en) 2016-02-04 2022-05-19 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered ANGPTL8 gene
CN109068621B (en) 2016-02-29 2021-07-20 再生元制药公司 Rodent with humanized TMPRSS gene
SI3462853T1 (en) 2016-06-03 2023-05-31 Regeneron Pharmaceuticals, Inc. Rodents expressing exogenous terminal deoxynucleotidyltransferase
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (en) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Preparation method and application of humanized gene modified animal model
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (en) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Preparation method and application of humanized modified animal model of CD47 gene
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
SG11202002456WA (en) 2017-11-30 2020-04-29 Regeneron Pharma Non-human animals comprising a humanized trkb locus
US11704983B2 (en) 2017-12-22 2023-07-18 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
WO2019122912A1 (en) 2017-12-22 2019-06-27 Ultrahaptics Limited Tracking in haptic systems
EP3772926A1 (en) 2018-03-26 2021-02-17 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
WO2019211616A1 (en) 2018-05-02 2019-11-07 Ultrahaptics Limited Blocking plate structure for improved acoustic transmission efficiency
KR20210031868A (en) * 2018-07-16 2021-03-23 리제너론 파마슈티칼스 인코포레이티드 Non-human animal model of DITRA disease and uses thereof
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
US11550395B2 (en) 2019-01-04 2023-01-10 Ultrahaptics Ip Ltd Mid-air haptic textures
CN114107385A (en) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 Humanized transgenic animal
WO2020206139A1 (en) 2019-04-04 2020-10-08 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized coagulation factor 12 locus
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
CN113853433A (en) * 2019-05-27 2021-12-28 转基因股份有限公司 Exon humanized mouse
CN113874510A (en) 2019-06-04 2021-12-31 瑞泽恩制药公司 Non-human animals including humanized TTR loci with beta glide mutations and methods of use
TW202112229A (en) 2019-06-07 2021-04-01 美商雷傑納榮製藥公司 Non-human animals comprising a humanized albumin locus
JP2022551944A (en) 2019-10-13 2022-12-14 ウルトラリープ リミテッド Dynamic capping with virtual microphones
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
US11169610B2 (en) 2019-11-08 2021-11-09 Ultraleap Limited Tracking techniques in haptic systems
CN111304246B (en) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 Humanized cytokine animal model, preparation method and application
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
KR20220133248A (en) * 2020-01-28 2022-10-04 리제너론 파마슈티칼스 인코포레이티드 Non-Human Animals Comprising Humanized PNPLA3 Locus and Methods of Use
CN116075221A (en) 2020-04-21 2023-05-05 瑞泽恩制药公司 Non-human animals with humanized CXCL13 genes
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
WO2022058738A1 (en) 2020-09-17 2022-03-24 Ultraleap Limited Ultrahapticons
WO2024073679A1 (en) 2022-09-29 2024-04-04 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786007A1 (en) * 1994-10-14 1997-07-30 Basf Aktiengesellschaft Transgenic nonhuman animal having functionally disrupted interleukin-1-beta converting enzyme gene
CN101829325A (en) 1994-10-21 2010-09-15 岸本忠三 The purposes of the antibody of IL-6 receptor in pharmaceutical compositions
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (en) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof
ES2667169T3 (en) 2004-10-19 2018-05-09 Regeneron Pharmaceuticals, Inc. Method to generate a homozygous non-human animal for genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
PL2041177T3 (en) 2006-06-02 2012-09-28 Regeneron Pharma High affinity antibodies to human il-6 receptor
PE20081216A1 (en) * 2006-09-01 2008-09-04 Therapeutic Human Polyclonals Inc ENHANCED EXPRESSION OF HUMAN OR HUMANIZED IMMUNOGLOBULIN IN NON-HUMAN TRANSGENIC ANIMALS
FR2942218A1 (en) 2009-02-13 2010-08-20 Eurocave Sa APPARATUS FOR SERVING GLASS OF A LIQUID, IN PARTICULAR WINE
EP4049535A1 (en) 2009-10-06 2022-08-31 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
HUE038684T2 (en) * 2009-12-21 2018-11-28 Regeneron Pharma Humanized fc gamma r mice
KR20230145500A (en) 2011-02-15 2023-10-17 리제너론 파마슈티칼스 인코포레이티드 Humanized m-csf mice
RU2722829C9 (en) * 2011-09-30 2020-09-22 Чугаи Сейяку Кабусики Кайся Antigen-binding molecule inducing an immune response to a target antigen
KR101921126B1 (en) 2011-10-28 2018-11-23 리제너론 파아마슈티컬스, 인크. Genetically modified major histocompatibility complex mice
PL3272214T3 (en) 2011-10-28 2020-06-29 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules
PT2818478T (en) 2011-10-28 2017-05-12 Regeneron Pharma Humanized il-6 and il-6 receptor

Also Published As

Publication number Publication date
WO2013063556A1 (en) 2013-05-02
EP2818478A1 (en) 2014-12-31
US20160278352A1 (en) 2016-09-29
ES2624605T3 (en) 2017-07-17
MX2014004900A (en) 2014-08-26
DK2818478T3 (en) 2017-05-22
MX358390B (en) 2018-08-17
RS53683B1 (en) 2015-04-30
IL243666A0 (en) 2016-03-31
JP2014532416A (en) 2014-12-08
SI2663575T1 (en) 2015-01-30
US10433528B2 (en) 2019-10-08
PT2818478T (en) 2017-05-12
US8878001B2 (en) 2014-11-04
HUE033400T2 (en) 2017-12-28
IL264508A (en) 2019-02-28
EP2663575A1 (en) 2013-11-20
CY1116614T1 (en) 2017-03-15
KR102084927B1 (en) 2020-03-06
SG10201600965YA (en) 2016-03-30
KR102234632B1 (en) 2021-04-02
IL243665A0 (en) 2016-03-31
SG10202100485XA (en) 2021-02-25
SMT201400187B (en) 2015-01-15
SI2818478T1 (en) 2017-07-31
HK1190408A1 (en) 2014-07-04
US20130117873A1 (en) 2013-05-09
US20220053742A1 (en) 2022-02-24
JP6120451B2 (en) 2017-04-26
US20150272092A1 (en) 2015-10-01
CN104039821A (en) 2014-09-10
ES2525368T3 (en) 2014-12-23
AU2015207889B2 (en) 2017-02-23
US20150013022A1 (en) 2015-01-08
US9125386B2 (en) 2015-09-08
US11102962B2 (en) 2021-08-31
MY186903A (en) 2021-08-26
HRP20141192T1 (en) 2015-02-13
US9078418B2 (en) 2015-07-14
PT2663575E (en) 2014-12-05
IL264508B (en) 2019-12-31
NZ709432A (en) 2015-12-24
IL243665B (en) 2018-02-28
PL2663575T3 (en) 2015-03-31
US9392777B2 (en) 2016-07-19
CN108866101A (en) 2018-11-23
EP2663575B1 (en) 2014-10-01
MY172726A (en) 2019-12-11
US10004211B2 (en) 2018-06-26
US9622460B2 (en) 2017-04-18
EP2818478B1 (en) 2017-02-01
JP2017035115A (en) 2017-02-16
US20180271071A1 (en) 2018-09-27
IL231896A0 (en) 2014-05-28
RU2017129763A3 (en) 2020-12-18
WO2013063556A4 (en) 2013-06-20
WO2013063556A8 (en) 2014-04-17
SG11201400945UA (en) 2014-04-28
NZ623145A (en) 2015-09-25
IL231896B (en) 2018-02-28
CA2853731C (en) 2021-05-18
HRP20170656T1 (en) 2017-06-30
KR20200024949A (en) 2020-03-09
BR112014008529A2 (en) 2017-04-18
RU2751240C2 (en) 2021-07-12
CY1118952T1 (en) 2018-01-10
RU2014121324A (en) 2015-12-10
US20170055506A1 (en) 2017-03-02
PL2818478T3 (en) 2017-09-29
US20200008407A1 (en) 2020-01-09
RU2017129763A (en) 2019-02-05
RS55949B1 (en) 2017-09-29
DK2663575T3 (en) 2014-12-15
RU2634417C2 (en) 2017-10-26
HK1205135A1 (en) 2015-12-11
CA2853731A1 (en) 2013-05-02
KR20140091024A (en) 2014-07-18
AU2015207889A1 (en) 2015-08-20
IL243666B (en) 2019-02-28
ZA201402635B (en) 2015-09-30
LT2818478T (en) 2017-06-12
US20150013023A1 (en) 2015-01-08

Similar Documents

Publication Publication Date Title
IN2014CN03920A (en)
PH12016502058A1 (en) Humanized il-4 and il-4r alpha animals
PH12019502292A1 (en) Methods and compositions for treatment of a genetic condition
MX2016003636A (en) Non-human animals having a humanized signal-regulatory protein gene.
MX363540B (en) Humanized il-7 rodents.
IN2014DN07853A (en)
SG10201900323SA (en) Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
MX2019005251A (en) Genetically modified non-human animals and methods of use thereof.
MX2013015311A (en) Pcsk9-binding polypeptides and methods of use.
NZ612297A (en) Glucagon analogs exhibiting gip receptor activity
TW201129697A (en) Herbicide-tolerant plants
PH12016502170A1 (en) Humanized dipeptidyl peptidase iv (dpp4) animals
EP2635879A4 (en) Systems and methods for generating updates of geological models
MY183189A (en) Non-human animals having a humanized a proliferation-inducing ligand gene
IN2014DN11201A (en)
PH12015502421A1 (en) Artificial transcription factors engineered to overcome endosomal entrapment
MX2012007898A (en) Methods of providing weight loss therapy in patients with major depression.
CA145378S (en) Laryngeal mask airway device
EP3619312A4 (en) Mature plant transfection using carbon nanotubes
MX367031B (en) Plants for production of therapeutic proteins.
SG11202101042SA (en) Gene therapy methods to control organ function
MX339605B (en) Improved process for production of recombinant human growth hormone.
AU327123S (en) A control head for use with dental equipment